TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive In Brief: Stetten’s Deputy, Von Euler, Takes Over At NIGMS; Sherman’s Replacement Probably Will Be In-House March 15, 1974
TCL Archive Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says September 6, 2002
